|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2005-06-15 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1999-09-15 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1942-05-07 |
Tacrolimus and Mycophenolate Versus Tacrolimus and Sirolimus vs. Neoral and Sirolimus Used in Combination in Cadaver and Non-HLA Identical Living Related Kidney Transplants
Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.
100 项与 Ayerst-Wyeth Pharmaceuticals, Inc. 相关的临床结果
0 项与 Ayerst-Wyeth Pharmaceuticals, Inc. 相关的专利(医药)
100 项与 Ayerst-Wyeth Pharmaceuticals, Inc. 相关的药物交易
100 项与 Ayerst-Wyeth Pharmaceuticals, Inc. 相关的转化医学